, Volume 1, Issue 2, pp 91–104 | Cite as

Investigation of metabolic myopathies by P-31 MRS using a standardized rest-exercise-recovery protocol: a survey of 800 explorations

  • D. Bendahan
  • S. Confort-Gouny
  • G. Kozak Ribbens
  • PJ. Cozzone


A standardized P-31 magnetic resonance spectroscopy (MRS) protocol for the exploration of muscle metabolism by P-31 MRS in trained and untrained subjects as well as in patients with intolerance to exercise has been developed to meet the specific requirements of a clinical environment. This protocol is based on a short-term intense exercise which is very informative and well accepted by volunteers and patients. Invariant metabolic parameters have been established to characterize the normal metabolic response to the protocol. As a matter of fact, the comparative analysis of normal and diseased muscle remains a major requirement to further define metabolic events surrounding muscle contraction and the metabolic anomalies underlying diseases. Deviations from normality can be directly interpreted in terms of specific pathologies in some favourable cases. In most cases, P-31 MRS provides valuable information which has to be processed in conjunction with traditional invasive biochemical, electrophysiological and histoenzymological tests. For malignant and exertional hyperthermias, P-31 MRS constitutes a diagnostic tool with 100% sensitivity, as compared to contracture tests. P-31 MRS has proved particularly useful in the therapeutic follow-up of palliative therapies (coenzyme Q treatment of mitochondriopathies) and in family investigations. It is now an accepted diagnostic tool in the array of tests which are used to characterize muscle disorders in clinical routine. This procedure is already approved for reimbursement in the public hospital system in Marseille, France.


P-31 MRS muscle bioenergetics metabolic myopathies diagnosis therapeutic follow-up 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hoult DI, Busby JW, Gadian DG, Radda JK, Richards RE and Seeley PJ (1974) Observation of tissue metabolites using P31 nuclear magnetic resonance.Nature 252: 285–287.Google Scholar
  2. 2.
    Ackerman JH, Groove TH, Wong G, Gadian DG and Radda GK (1980) Mapping of metabolites in whole animals by P31 NMR using surface coil.Nature 283: 167–170.Google Scholar
  3. 3.
    Chance B, Eleff S, Leigh JS, Sokolow DP and Sapega AA (1981) Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: A gated P31 NMR study.Proc Natl Acad Sci USA 78: 6714–6718.Google Scholar
  4. 4.
    Taylor DJ, Bore PJ, Styles P, Gadian DG and Radda G (1983) Bioenergetics of intact human muscle, a31P nuclear magnetic resonance study.Mol Biol Med 1: 77–94.Google Scholar
  5. 5.
    Bernard M, Canioni P and Cozzone PJ (1983) Etude du métabolisme cellulairein vivo par resonance magnétique nucléaire du phosphore-31.Biochimie 65: 449–470.Google Scholar
  6. 6.
    Canioni P and Cozzone PJ (1986) InDocumenta, Imagerie far IRM et Rhumatologie (H. Roux, J. Lavieille eds) Paris: Ciba Giegy, pp. 34–51.Google Scholar
  7. 7.
    Sapega AA, Sokolow DP, Graham TJ and Chance B (1987) Phosphorus nuclear magnetic resonance: a non-invasive technique for the study of muscle bioenergetics during exercise.Medecine and science in sport and exercise 19: 410–419.Google Scholar
  8. 8.
    Rees D, Smith MB, Harley J and Radda GK (1989)In vivo functioning of creatine phosphokinase in human forearm muscle, studied by 31-P NMR saturation transfer.Magn Res Med 9: 39–52.Google Scholar
  9. 9.
    Burt CT, Gloneck T and Barany M (1976) Analysis of phosphate metabolites, the intracellular pH and the state of adenosine triphosphate in intact muscle by Phosphorus Nuclear Magnetic Resonance.J Biol Chem 251: 2584–2591.Google Scholar
  10. 10.
    Dawson MJ, Gadian DG and Wilkie DR (1977) Contraction and recovery of living muscles studied by P31 Nuclear Magnetic Resonance.J Physiol 267: 703–735.Google Scholar
  11. 11.
    Chance B, Eleff S and Leigh JS (1980) Non invasive, non destructive approaches to cell bioenergetics.Proc Natl Acad Sci USA 77: 7430–7434.Google Scholar
  12. 12.
    Meyer RA, Kushmerick MJ and Brown TR (1982) Application of P31-NMR spectroscopy to the study of striated muscle metabolism.Amer J Physiol 242: C1-C11.Google Scholar
  13. 13.
    Renou JP, Canioni P, Gatelier P, Valin C and Cozzone PJ (1986) Phosphorus-31 nuclear magnetic resonance study ofpost mortem catabolism and intracellular pH in intact excised rabbit muscle.Biochimie 68: 543–554.Google Scholar
  14. 14.
    Radda K (1984) Control of bioenergetics: from cells to man by phosphorus nuclear-magnetic resonance-spectroscopy.Eighteenth CIBA Medal Lecture 14: 517–525.Google Scholar
  15. 15.
    Achten E, Van Cauteren M, Willem R, Luypaert R, Malaisse WJ, Van Bosh G, Delangle G, De Meirleir K and Osteaux M (1990) P-31 NMR Spectroscopy and the metabolic properties of different muscle fibers.J Appl Physiol 68: 644–649.Google Scholar
  16. 16.
    Chance B, Leigh, JS, Smith D, Nioka S and Clark BJ (1986) Phosphorus Magnetic Resonance Spectroscopy of the role of mitochondrial in the disease process.Ann N Y Acad Sci 488: 140–153.Google Scholar
  17. 17.
    Duboc D, Jehenson P, Tran-Dinh S, Marsac C, Syrota A and Fardeau M (1987) Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis.Neurology 37: 663–671.Google Scholar
  18. 18.
    Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M and Falconer-Smith J (1981) Examination of a case of suspected McArdle's syndrome by31P nuclear magnetic resonance.New Eng J Med 28: 1338–1342.Google Scholar
  19. 19.
    Bendahan D, Confort-Gouny S, Kozak-Reiss G and Cozzone PJ (1992) 31-P NMR Characterization of the metabolic anomalies associated to the lack of glycogen phosphorylase activity in human forearm muscle.Biochem Biophys Res Commun 185: 16–21.Google Scholar
  20. 20.
    Bendahan D, Confort-Gouny S, Kozak-Reiss G, Fontanarava E and Cozzone PJ (1992) 31-P NMR and ergometer exercise tests as evidence for muscle oxidative performance improvement with coenzyme Q.Neurology 42: 1203–1208.Google Scholar
  21. 21.
    Bendahan D, Confort-Gouny S, Kozak-Reiss G and Cozzone PJ (1990) Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined byin vivo 31-P NMR spectroscopy.FEBS Lett 272: 155–158.Google Scholar
  22. 22.
    Bendahan D, Kozak-Reiss G, Confort-Gouny S and Cozzone PJ (1991) InBook of Abstracts of 10th Annual Meeting of the Society Magnetic Resonance in Medicine (SMRM eds) Berkeley (USA)2: 545.Google Scholar
  23. 23.
    Cozzone PJ, Bendahan D, Confort-Gouny S and Kozak-Reiss G (1991) InCiba-Geigy Documenta, Imagerie par RMN et Rhumatologie (H. Roux, J. Lavieille eds)2: 236–249.Google Scholar
  24. 24.
    Bendahan D, Kozak-Reiss G, Confort-Gouny S and Cozzone PJ (1990) Pi trapping in glycogenolytic pathway can explain Pi disappearance during recovery from muscular exercise: A31P NMR study in the Human.FEBS Lett 269: 402–405.Google Scholar
  25. 25.
    Bendahan D, Confort-Gouny S, Rodet L, Kozak-Reiss G and Cozzone PJ (1991) InBook of Abstracts of 11th Annual Meeting of the Society Magnetic Resonance in Medicine (SMRM eds) Berkeley (USA)2: 2722.Google Scholar
  26. 26.
    Hayes DJ, Taylor DJ, Bore PJ, Hilton-Jones D, Arnold DL, Squier MV, Gent AE and Radda GK (1987) An unusual metabolic myopathy: a malate-aspartate shuttle defect.J Neurol Sci 82: 27–39.Google Scholar
  27. 27.
    Taylor DJ, Brosnan MJ, Arnold DL, Bore PJ, Styles P, Walton J and Radda G (1988) K Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome.J Neurol Neuros and Psychiatry 51: 1425–1433.Google Scholar
  28. 28.
    Arnold DL, Bore PJ, Radda GK, Styles P and Taylor DJ (1984) Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome.The Lancet 23: 1367–1369.Google Scholar
  29. 29.
    Argov Z, Renshaw PF, Boden B, Winokur A and Bank J (1988) Effects of thyroid hormones on skeletal muscle bioenergetics:In vivo phosphorus-31 magnetic resonance spectroscopy study of human and rats.J Clin Invest 81: 1695–1701.Google Scholar
  30. 30.
    Kaminsky P, Robin-Lherbier B, Brunotte F, Escanye JM, Walker P, Klein M, Robert J and Duc M (1992) Energetic metabolism in hypothyroid skeletal muscle as studied by phosphorus magnetic resonance spectroscopy.J Clin Endocrinol Metab 74: 124–129.Google Scholar
  31. 31.
    Kozak Reiss G, Desmoulin F, Martin CF, Monin G, Renou JP, Canioni P and Cozzone PJ (1991)In vitro correlation between force and energy metabolism in porcine malignant hyperthermic muscle studied by 31 P NMR.Arch Biochem Biophys 287: 312–319.Google Scholar
  32. 32.
    Kozak Ribbens G, Confort-Gouny S, Rodet L, Bendahan D, Miri A, Talmant A, Monin G and Cozzone PJ (1992) Non-rigid malignant hyperthermia crisis studied in an anesthetized pig byin vivo phosphorus-31 NMR spectroscopy. 1992; Submitted to publication.Google Scholar
  33. 33.
    Kozak Ribbens G, Coursange F and Aubert M (1991) Hyperthermies malignes — Editions techniques-Encycl. Méd. Chir. (Paris-France), Techniques chirurgicales — Anesthésie-Réanimation, 36412 E10, 18p.Google Scholar
  34. 34.
    Payen JF, Bourdon L, Mezin P, Jacquot C, Le Bas JF, Stieglitz P and Benabid AL (1991) Susceptibility to malignant hyperthermia detected non-invasively.The Lancet 337: 1550–1551.Google Scholar
  35. 35.
    Olgin J, Argow Z, Rosenberg H, Tuchler M and Chance B (1988) Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy.Anesthesiology 68: 507–513.Google Scholar
  36. 36.
    Fleckenstein JL, Haller RG, Lewis SF, Archer BT, Barker BR, Payne J, Parkey RW and Peshock RM (1991) Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease.J Appl Physiol 71: 961–969.Google Scholar
  37. 37.
    De Kerviler E, Leroy-Willig A, Jehenson P, Duboc D, Eymard B and Syrota A (1991) Exercise-induced muscle modifications: Study of healthy subjects and patients with metabolic myopathies with MR imaging and 31-P NMR spectroscopy.Radiology 181: 259–264.Google Scholar
  38. 38.
    Jue T, Rothman DL, Shulman GI, Tavitian BA, Defronzo RA and Shulman RG (1989) Direct observation of glycogen synthesis in human muscle with C-13 NMR.Proc Natl Acad Sci 86: 4489–4491.Google Scholar
  39. 39.
    Shulman GI, Rothman DL, Jue T, Stein P, Defronzo RA and Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by C-13 nuclear magnetic resonance spectroscopy.New Eng J Med 322: 223–225.Google Scholar
  40. 40.
    Beckman N, Seelig J and Wick H (1990) Analysis of glycogen storage disease by in vivo C-13 NMR: comparison of normal volunteers with a patient.Magn Reson Med 16: 150–160.Google Scholar

Copyright information

© Chapman & Hall 1993

Authors and Affiliations

  • D. Bendahan
    • 1
  • S. Confort-Gouny
    • 1
  • G. Kozak Ribbens
    • 1
  • PJ. Cozzone
    • 1
  1. 1.Centre de Résonance Magnétique Biologique et Médicale (CRMBM)URA CNRS 1186 — Faculté de Médecine de MarseilleMarseilleFrance

Personalised recommendations